Comparison of Monoamine Oxidase-A, Aβ Plaques, Tau, and Translocator Protein Levels in Postmortem Human Alzheimer’s Disease Brain
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241310808 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Amina U Syed und 7 weiteren Autor:innen. Beteiligte Einrichtung: Preclinical Imaging, Department of Radiological Sciences, University of California-Irvine, Irvine, CA 92697, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Themen: Demenz
Abstract (Originalsprache)
Increased monoamine oxidase-A (MAO-A) activity in Alzheimer’s disease (AD) may be detrimental to the point of neurodegeneration. To assess MAO-A activity in AD, we compared four biomarkers, Aβ plaques, tau, translocator protein (TSPO), and MAO-A in postmortem AD. Radiotracers were [18F]FAZIN3 for MAO-A, [18F]flotaza and [125I]IBETA for Aβ plaques, [124/125I]IPPI for tau, and [18F]FEPPA for TSPO imaging. Brain sections of the anterior cingulate (AC; gray matter GM) and corpus callosum (CC; white matter WM) from cognitively normal control (CN, n = 6) and AD (n = 6) subjects were imaged using autoradiography and immunostaining. Using competition with clorgyline and (R)-deprenyl, the binding of [18F]FAZIN3 was confirmed to be selective to MAO-A levels in the AD brain sections. Increases in MAO-A, Aβ plaque, tau, and TSPO activity were found in the AD brains compared to the control brains. The [18F]FAZIN3 ratio in AD GM versus CN GM was 2.80, suggesting a 180% increase in MAO-A activity. Using GM-to-WM ratios of AD versus CN, a >50% increase in MAO-A activity was observed (AD/CN = 1.58). Linear positive correlations of [18F]FAZIN3 with [18F]flotaza, [125I]IBETA, and [125I]IPPI were measured and suggested an increase in MAO-A activity with increases in Aβ plaques and tau activity. Our results support the finding that MAO-A activity is elevated in the anterior cingulate cortex in AD and thus may provide a new biomarker for AD in this brain region.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Preclinical Imaging, Department of Radiological Sciences, University of California-Irvine, Irvine, CA 92697, USA.
ORCID-Profile: Jogeshwar Mukherjee
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Syed, A. U., Liang, C., Patel, K. K., Mondal, R., Kamalia, V. M., Moran, T. R., Ahmed, S. T., & Mukherjee, J. (2023). Comparison of Monoamine Oxidase-A, Aβ Plaques, Tau, and Translocator Protein Levels in Postmortem Human Alzheimer’s Disease Brain. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241310808
Vancouver
Syed AU, Liang C, Patel KK, Mondal R, Kamalia VM, Moran TR, et al. Comparison of Monoamine Oxidase-A, Aβ Plaques, Tau, and Translocator Protein Levels in Postmortem Human Alzheimer’s Disease Brain. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241310808
BibTeX
@article{Syed2023,
author = {Syed, Amina U and Liang, Christopher and Patel, Krystal K and Mondal, Rommani and Kamalia, Vallabhi M and Moran, Taylor R and Ahmed, Shamiha T and Mukherjee, Jogeshwar},
title = {Comparison of Monoamine Oxidase-A, Aβ Plaques, Tau, and Translocator Protein Levels in Postmortem Human Alzheimer’s Disease Brain},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241310808}
}
EUVIMED